Navigation Links
Innovative Deep Vein Thrombosis Treatment Yields Priceless Payoff
Date:11/6/2008

Phoenix Interventional Radiologist Aaron Wittenberg, MD, uses an investor's technology to yield the ultimate return: saving someone else's life

PHOENIX, Nov. 6 /PRNewswire-USNewswire/ -- When Scottsdale businessman Warren Kaplan decided a decade ago to invest in Possis Medical, he had no idea that an innovative medical product Possis would develop would - in the hands of a gifted interventional radiologist - save his daughter's life.

"I liked their business model," Kaplan said. "They were inventing products with great potential, but they were also marketing them in a way that would ensure continuing sales."

A savvy investor, Kaplan not only checked out the company before he bought its stock, but kept in touch, and continued to research products in development.

With support from Kaplan's investment, Possis pioneered technology to save the lives and limbs of patients suffering from circulation-blocking blood clots. They manufactured medical machinery to quickly, safely and effectively remove deep vein thromboses (DVT), the medical name for blood clots in the veins.

The Anatomy of a Blood Clot

Whenever a blood vessel - a vein or an artery - is injured, platelets in the blood trigger chemical reactions that form strands into a meshwork, a screen that traps more platelets. Thus, a clot is formed. On the skin, this stops the bleeding and starts the healing.

Inside the vein or artery, however, the clot will begin to block blood flow. Pressure in front of the blockage builds up. Sometimes vessel walls can burst or leak.

Beyond the blocked area, without fresh blood, the muscle tissue is damaged, sometimes forever. This is often painful and can be dangerous. Pieces of the clot can break off and be carried to the lungs, causing a condition called pulmonary embolism, leading to physical disability - even death.

If the clot remains in the vein over time, patients can develop DVT symptoms such as chronic pain, swelling or even skin ulcerations that can lead to limb loss.

A Pharmaceutical Vacuum Cleaner

Possis' AngioJet Rheolytic Thrombectomy System, which premiered in 1997, remains the medical world's leading mechanical clot-removing system. Think of it as a tiny, sensitive, sophisticated pharmaceutical vacuum cleaner. Because it works with catheters threaded through a vein to reach the clot, it requires no incisions or surgery.

As its clot-busting drug physically breaks the clot into pieces, the vacuum catheter sucks the tiny bits out of the body. A filter prevents any bits from escaping into the blood stream where they could wreak havoc in other parts of the body.

By the time his daughter, Kim, was diagnosed with a DVT last fall, Kaplan was well-aware of the latest advances and performance capabilities of AngioJet products. When doctors at the first hospital Kim was taken used only blood thinners for treatment, Kaplan started asking questions.

"I tracked down their interventional radiologists, the doctors who do these procedures," Kaplan said. "What I found was that they had the AngioJet technology, but they only used it for cardiac clots. They didn't know how to use it to treat DVTs."

Life-Saving Call

Appalled, Kaplan got on the phone to Possis, tracked down their Arizona representative, Alan Poland, and asked a blunt question. "If it were your mother who needed treatment for DVT, which doctor would you call for help?"

"I didn't hesitate," Poland said. "I told Kaplan to contact Aaron Wittenberg, MD, a board-certified interventional radiologist at John C. Lincoln Deer Valley Hospital."

"Dr. Wittenberg not only has extensive experience in using the AngioJet, but he is amazingly down-to-earth, compassionate and easy to talk with," Kaplan observed.

"He used ultrasound to diagnose the extent of Kim's clot - which extended from her thigh to her abdomen - and then he gave us a clear description of her condition and what he could do to help."

Wittenberg immediately scheduled Kim for the AngioJet DVT treatment at John C. Lincoln Deer Valley Hospital, during which he inserted the catheter into the vein behind her knee and vacuumed the clot out of her vein.

A filter stayed in place for the next four to five months to be sure that no part of the clot was able to travel out of her leg into her lungs.

"You have to be aggressive in treating these larger blood clots in legs in order to have optimal outcomes," Wittenberg said.

"In serious cases like Kim's, blood thinners such as Heparin or Coumadin just won't do the job. But by using the AngioJet, we can get rid of the clot in a matter of minutes. This prevents any long-term damage from the DVT."

"Dr. Wittenberg took great care of my daughter," Kaplan said, "So did the entire staff at the Deer Valley hospital. Every nurse who took care of her, from presurgery on through her stay, was just wonderful. I am very grateful to all of them."

Because of its seriousness, Acting Surgeon General Steven K. Galson recently urged all Americans to learn about and prevent DVT, a treatable but often silent condition.

Learn more about the Deep Vein Thrombosis Center at John C. Lincoln Hospital at http://www.JCL.com/dvt .


'/>"/>
SOURCE John C. Lincoln Health Network
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MCG receives $100,000 Grand Challenges Explorations grant for innovative global health research
2. Weill Cornell Medical College receives 2 $100,000 grants for innovative global health research
3. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
4. Purina(R) Pro Plan(R) Introduces Innovative Blend of Tender and Hard Kibbles
5. Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion
6. Innovative Atrial Fibrillation (AF) Catheter Ablation System From Ablation Frontiers is Subject of Two Abstracts at Heart Rhythm Congress UK
7. HireRight Named to Deloitte Technology Fast 50 for the Sixth Year in a Row : Attributes Customer Focus and Innovative Screening Solutions to its 230 Percent Revenue Growth
8. Perfect Pushup Introduces Innovative Travel Fitness Solution; Mobile Unit Designed for Travelers Hits Retail This Month
9. NIH Awards a Phase I Small Business Innovative Research Grant on "Novel Laser Scanning Technology for Computed Radiography" to VIXAR and iCRco
10. Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
11. [video] Hojabr Alimi, CEO of Oculus Innovative Sciences, Inc. Discusses Reduction of Planned Expenses on WallSt.nets 3-Minute Press Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... According to an article ... account for a significant portion of hernia repairs throughout the United States. Commenting on ... Hernia Center notes that this trend has not only been expected, but it seems ...
(Date:2/12/2016)... ... 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett ... of these scholarships is to encourage applicants to pursue a degree in their field ... two parishes. , “We have available jobs in St. Landry and Evangeline Parishes ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... community at its 10th anniversary Fashion Luncheon on Monday, February 8, 2016. The ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... cycle of pharmaceutical products, garnering increased attention from all stakeholders in the development ...
(Date:2/12/2016)... ... 12, 2016 , ... As a former television executive, owner Tal Rabinowitz knows ... time to decompress, Rabinowitz found herself drawn to a casual meditation class while working ... her life, implementing a 20-minute-per-day meditation practice with her team. After her tenure at ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Eli Lilly and Company (NYSE: LLY ) today announced ... vitamin regimen patent would not presently be infringed by Actavis ... , Italy and Spain ... dextrose solution.  --> --> ... held that Lilly,s patent would be indirectly infringed by Actavis ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis ... completed a $47.1 million Series D preferred ... Asset Management, Hillhouse Capital Group and venBio ... Venture Investments, AJU IB Investment, and Epidarex ... used to further advance clinical trials in ...
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
Breaking Medicine Technology: